Workflow
GUANGDONG DRIVE BIO-TECH CO.(838275)
icon
Search documents
驱动力(838275) - 关于召开2024年第五次临时股东大会通知公告(更正公告)
2024-12-09 16:00
更正前: 证券代码:838275 证券简称:驱动力 公告编号:2024-133 (更正公告) 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、误 导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带法 律责任。 广东驱动力生物科技集团股份有限公司((下简简称公公司)) 2024 年 11 月 29 日在北京证券交易所官网(www.bse.cn)披露了《关 召开 2024 年第五次 临时股东大会通知公告(提供网络投票)》。经事后审核,该公告部分内容需要 进行更正,具体情况如简: ((五)会召召开日和和时 ((五)会召召开日和和时 除上述更正内容外,原公告其他内容不变。因本次更正给投资者带来的不便, 公司深表歉意,公司将引下为戒,持续做好信息披露工作,敬请广大投资者谅解。 特此公告。 广东驱动力生物科技集团股份有限公司 董事会 2024 年 12 月 10 日 1、现场会召召开时 :2024 年 12 月 16 日 14:30。 2、网络投票起止时 :2024年12月13日15:00—2024年12月16日15:00。 更正后: 1、现场会召召开时 :2024 年 12 月 ...
驱动力(838275) - 关于召开2024年第五次临时股东大会通知公告(更正后)
2024-12-09 16:00
证券代码:838275 证券简称:驱动力 公告编号:2024-134 广东驱动力生物科技集团股份有限公司 关于召开 2024 年第五次临时股东大会通知公告(提供网络投票) (更正后) 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 (一)股东大会届次 本次会议为 2024 年第五次临时股东大会。 (二)召集人 本次股东大会的召集人为董事会。 2024 年 11 月 29 日,公司召开了第四届董事会第四次会议,审议通过了《关 于提请召开 2024 年第五次临时股东大会的议案》,公司董事会据此召开本次股东 大会。 (三)会议召开的合法性、合规性 本次会议的召集、召开符合有关法律、行政法规、规范性文件和《公司章程》 的规定,无需其他相关部门批准或履行必要程序。 (四)会议召开方式 一、会议召开基本情况 2、网络投票起止时间:2024 年 12 月 15 日 15:00—2024 年 12 月 16 日 15:00。 登记在册的股东可通过中国证券登记结算有限责任公司(以下简称"中国结 算")持有人大会网络投票系 ...
专访特斯拉对外事务大区负责人蒋丹:在深圳向全球展示特斯拉创新驱动力,拥抱看得见的AI出行方式
Core Viewpoint - The 2024 Shenzhen Global Investment Conference showcased Tesla's Cybertruck, highlighting the company's commitment to technological innovation and its strategic importance in the Shenzhen market [1][5]. Group 1: Tesla's Development in Shenzhen - Tesla has established over 35 stores and more than 60 Supercharger stations in Shenzhen since entering the market in 2014, making it a key strategic market for the company [1][2]. - The Shenzhen Longhua Tesla Center is one of the busiest delivery centers in China, reflecting Tesla's significant operational presence in the region [1]. Group 2: Charging Network and Infrastructure - As of June 2023, Tesla has built over 60 Supercharger stations and more than 570 charging piles in Shenzhen, creating a comprehensive charging network that supports green travel [2]. - Tesla has also established China's largest destination charging station in Shenzhen, equipped with 188 charging piles, enhancing user convenience [2]. Group 3: Business Environment and Support - Tesla appreciates Shenzhen's supportive business environment, citing government policies and services that facilitate the growth of electric vehicle consumption [3]. - The recent "trade-in" subsidy policy has stimulated consumer activity, with in-store traffic increasing by 20% and orders rising over 15% year-on-year [3]. Group 4: Future Directions and Innovations - Tesla plans to invest approximately $10 billion (about 72.5 billion RMB) in artificial intelligence for comprehensive training and reasoning in 2024, aiming to enhance consumer access to technology [4]. - The company intends to continue expanding its service and charging infrastructure in Shenzhen, focusing on sustainable travel and the integration of AI in its products [5]. Group 5: Product Showcase and Market Strategy - The Cybertruck was showcased at the conference to demonstrate Tesla's innovative technology and design, although there are currently no plans for its sale in China [5]. - Tesla remains confident in the Shenzhen market and aims to contribute to the city's high-quality development by offering more high-quality electric vehicles and AI products [5].
驱动力(838275) - 投资者关系活动记录表
2024-12-06 11:21
Group 1: Investor Relations Activity Overview - The investor relations activity was held on December 5, 2024, at the company meeting room, attended by various investment firms and individual investors [2] - Key personnel present included the Chairman and General Manager Liu Pingxiang, controlling shareholder Liu Jinping, Board Secretary Ye Junqiang, and Deputy Financial Director Yang Na [3] Group 2: Company Business and Market Insights - The company has previously engaged in the pet food sector, specifically cat food aimed at enhancing immunity, but this segment currently represents a very small portion of its overall business [4] - There is significant market demand for hematopoietic nutritional products due to modern farming practices leading to anemia in livestock, which affects growth and meat quality [5] - The company's main business involves the research, production, and sales of additives that enhance animal blood production, but its current market share remains relatively small [6] Group 3: Financial Performance and Projections - The company's gross profit margin increased in the first three quarters of 2024 due to a strategic focus on higher-margin products, despite a decline in lower-margin product sales [7] - Although revenue has decreased this year, net profit has risen, attributed to improved sales structure and reduced credit impairment losses, among other factors [8] - The company aims to continue driving innovation and market expansion to deliver better returns to investors [9]
驱动力(838275) - 投资者关系活动记录表
2024-12-06 09:59
Group 1: Investor Relations Activity Overview - The investor relations activity was held on December 5, 2024, at the company meeting room [2] - Attendees included various investment firms and individual investors [2] - Company representatives included the Chairman, General Manager, and other key executives [3] Group 2: Company Business and Market Insights - The company has previously engaged in the pet food sector, but this currently represents a small portion of its business [4] - There is significant market demand for hematopoietic nutritional products due to modern farming practices leading to anemia in livestock [5] - The company's main business involves developing and selling additives that enhance animal blood production, but its market share remains relatively small [6] Group 3: Financial Performance and Projections - The company's gross profit margin increased in the first three quarters of 2024 due to a shift in focus towards higher-margin products [7] - Despite a decline in revenue, net profit increased in 2024, attributed to improved sales structure and reduced credit impairment losses [8] - The company aims to continue innovation and market expansion to enhance performance and returns for investors [9]
驱动力(838275) - 投资者关系活动记录表
2024-12-05 16:00
证券代码:838275 证券简称:驱动力 公告编号:2024-132 广东驱动力生物科技集团股份有限公司 投资者关系活动记录表 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 投资者关系活动类别 √特定对象调研 □业绩说明会 □媒体采访 √现场参观 参会单位及人员:广东力量基金、广东动量资本、广州量量资产、唐叁藏科 技、磊垚资本、广东臻远基金、深圳巨鹿投资、点亮咨询、深圳高盛世纪投资、 海通证券、浙商证券和个人投资者。 上市公司接待人员: 公司董事长、总经理刘平祥先生;公司控股股东刘金萍女士;董事会秘书叶 军强先生;财务副总监杨娜女士 三、 投资者关系活动主要内容 □新闻发布会 □分析师会议 □路演活动 □其他 二、 投资者关系活动情况 活动时间:2024 年 12 月 5 日 活动地点:公司会议室 2024 年公司积极调整业务结构,聚焦优势领域,在前三季度低毛利率的产 品(造血系列 3)收入规模有所下降,但较高毛利率的产品(造血系列 1、2)收 入上升,因此导致综合毛利率有所提高。 5、公司今年 ...
驱动力(838275)交易公开信息
2024-12-03 10:41
| | 公告日期 2024-12-03 异常期间 | | 无 | | | | --- | --- | --- | --- | --- | --- | | | 驱动力(838275) 连续竞价 (股) | 成交数量 | 32016427.0 | 成交金额(万 元) | 38080.72 | | | 涉及事项 当日价格振幅达到30%的前5只股票 | | | | | | 买/卖 | 营业部或交易单元名称 | | | 买入金额(元) | 卖出金额(元) | | 买1 | 国信证券股份有限公司深圳互联网分公司 | | | 5720981.12 | 616234.54 | | 买2 | 东方财富证券股份有限公司拉萨团结路第二证券营业部 | | | 5069779.9 | 1732155.91 | | 买3 | 东方财富证券股份有限公司拉萨东环路第一证券营业部 | | | 4673607.89 | 2662469.47 | | 买4 | 东方证券股份有限公司太原平阳路营业部 | | | 4487511.24 | 115595.5 | | 买5 | 平安证券股份有限公司深圳深南大道证券营业部 | | | 4009146.6 ...
驱动力龙虎榜数据(12月3日)
证券时报网讯,驱动力(838275)今日下跌8.80%,全天换手率35.56%,成交额3.81亿元,振幅 35.03%。 龙虎榜数据显示,营业部席位合计净卖出1724.71万元。 北交所公开信息显示,当日该股因日价格振幅达35.03%上榜,营业部席位合计净卖出1724.71万元。 证券时报•数据宝统计显示,上榜的前五大买卖营业部合计成交6517.56万元,其中,买入成交额为 2396.42万元,卖出成交额为4121.13万元,合计净卖出1724.71万元。 ...
北京证券交易所交易公开信息(2024-12-03)
2024-12-03 10:34
| 日期 | 代码 | 简称 | 成交数量(股) | 成交金额(万元) | 披露原因 | | --- | --- | --- | --- | --- | --- | | 2024-12- | | 惠丰钻石 | | | 当日收盘价涨幅达到30.00% | | 03 | 839725 | | 9898163 | 29592.02 | | | 2024-12- | 833943 | 优机股份 | 14572132.0 | 32391.54 | 当日收盘价涨幅达到29.96% | | 03 | | | | | | | 2024-12- | 831641 | 格利尔 | 2639978 | 5966.35 | 当日收盘价涨幅达到29.96% | | 03 | | | | | | | 2024-12- | 835207 | 众诚科技 | 24500851.0 | 68123.93 | 当日收盘价涨幅达到23.83% | | 03 | | | | | | | 2024-12- | 835207 | 众诚科技 | 24500851.0 | 68123.93 | 当日价格振幅达到35.06% | | 03 | | | | | ...
驱动力:股票交易异常波动公告
2024-12-02 11:47
1、 关注问题: (1)前期公告的事项是否取得重大进展或变化,前期披露的公告是否需要更正、补充; (2)是否存在可能或已经对本公司股票交易价格产生较大影响的媒体报道或市场传闻, 是否涉及热点概念事项; 证券代码:838275 证券简称:驱动力 公告编号:2024-131 广东驱动力生物科技集团股份有限公司股票交易异常波动公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 一、股票交易异常波动的具体情况 公司股票最近 2 个有成交的交易日(2024 年 11 月 29 日至 12 月 2 日)以内收盘价涨幅 偏离值累计达到 46.69%,根据《北京证券交易所交易规则(试行)》的有关规定,属于股票 交易异常波动情形。 二、公司关注并核实的相关情况 前期公告的事项不存在需要更正、补充之处,或取得重大进展或变化;未发现可能或已 经对本公司股票交易价格产生较大影响的媒体报道或市场传闻,不涉及热点概念事项;近期 公司经营情况及内外部经营环境未发生重大变化;公司、控股股东和实际控制人不存在关于 本公司的应披露而未披露 ...